Washington University School of Medicine received a $32 million National Institute on Aging (NIA) grant to expand its longitudinal Alzheimer’s research program through 2031. The study aims to evaluate real-world treatments and broaden community participation. For Alzheimer’s R&D and trial ecosystems, the award signals continued federal support for pragmatic evidence generation and enrollment expansion—often a gating factor for translation beyond controlled clinical settings. —